Idenix (IDIX) announces removal of partial clinical hold on HCV nucleotide inhibitor, IDX184
Go back to Idenix (IDIX) announces removal of partial clinical hold on HCV nucleotide inhibitor, IDX184| Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX) | Delayed: 24.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.50 | 52 Week High | $24.50 | |||
| Open | $9.18 | 52 Week Low | $4.81 | |||
| Day High | $24.50 | P/E | N/A | |||
| Day Low | $24.50 | EPS | $-0.89 | |||
| Volume | 5,300 | |||||
